產(chǎn)品詳情
簡單介紹：
Anti-CRABP1/Retinol binding protein抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CRABP1/Retinol binding protein抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CRABP1/Retinol binding protein
Cat. Number:
Anti-CRABP1/Retinol binding protein抗體KL-6442R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
RBP2 is an abundant protein present in the smallintestinal epithelium. It is thought to participate in the uptakeand/or intracellularAnti-CRABP1/Retinol binding protein抗體 metabolism of vitamin A. Vitamin A is afat-soluble vitamin necessary for growth, reproduction,differentiation of epithelial tissues, and vision. RBP2 may alsomodulate the supply of retinoic acid to the nuclei of endometrialcells during the menstrual cycle.
Also known as:
Cellular retinoic acid binding protein 1; Cellular retinoic acid-binding protein 1; Cellular retinoic acid-binding protein I; CRABP 1;Anti-CRABP1/Retinol binding protein抗體 CRABP; CRABP I; CRABP-I; Crabp1; CRABPI; RABP1_HUMAN; RBP 5; RBP5; Retinoic acid binding protein I cellular.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Anti-CRABP1/Retinol binding protein抗體Rat, Chicken, Dog, Pig, Cow, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Retinol binding protein (88-135aa).
●
Predicted Molecular Weight: 16kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications. Anti-CRABP1/Retinol binding protein抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-CRABP1/Retinol binding protein抗體
Optimal working dilutions must be determined by the end user.
